Development and characterization of floating microballoons for oral delivery of cinnarizine by a factorial design

References

• Akiyama Y, Nagahara N, Kashihara T, Hirai S, Toguchi H. In vitro and in vivo evaluation of mucoadhesive microspheres prepared for the gastrointestinal tract using polyglycerol esters of fatty acids and a poly (acrylic acid) derivative. Pharmaceutical Research 1995; 12: 397–405
   PubMed Web of Science ®Google Scholar
• Costa P, Manuel J, Lobo S. Modeling and comparison of dissolution profiles. European Journal of Pharmaceutical Sciences 2001; 13: 123–133
   PubMed Web of Science ®Google Scholar
• Desai S, Bolton S. A floating controlled-release drug delivery system: In vitro-in vivo evaluation. Pharmaceutical Research 1993; 10: 1321–1325
   PubMed Web of Science ®Google Scholar
• Deshpande AA, Rhodes CT, Shah NH, Malick AW. Controlled-release drug delivery systems for prolonged gastric residence: An overview. Drug Development and Industrial Pharmacy 1996; 22: 531–539
   Web of Science ®Google Scholar
• El-Kamel AH, Sokar MS, Al Gamal SS, Naggar VF. Preparation and evaluation of ketoporofen floating oral delivery system. International Journal of Pharmaceutics 2001; 220: 13–21
   PubMed Web of Science ®Google Scholar
• Fix JA, Cargill R, Engle K. Controlled gastric emptying. Part 3. Gastric residence time of a nondisintegrating geometric shape in human volunteers. Pharmaceutical Research 1993; 10: 1087–1089
   PubMed Web of Science ®Google Scholar
• Gohel MC, Panchal MK. Novel use of similarity factors f2 and Sd for development of diltiazem HCl modified-Release tablets using a 32 factorial design. Drug Development and Industrial Pharmacy 2002; 28(1)77–87
   PubMed Web of Science ®Google Scholar
• Jain SK, Awasthi AM, Jain NK, Agrawal GP. Calcium silicate based microspheres of repaglinide for gastroretentive floating drug delivery: Preparation and in vitro characterization. Journal of Controlled Release 2005; 107(2)300–309
   PubMed Web of Science ®Google Scholar
• Jarvinen T, Jarvinen K, Schwarting N, Stella VJ. beta-cyclodextrin derivatives, SBE4-beta-CD and HP-beta-CD, increase the oral bioavailability of cinnarizine in beagle dogs. Journal of Pharmaceutical Sciences 1995; 84(3)295–299
   PubMed Web of Science ®Google Scholar
• Joseph NJ, Lakshmi S, Jayakrishnan A. A floating-type oral dosage form for piroxicam based on hollow polycarbonate microspheres: In vitro and in vivo evaluation in rabbits. Journal of Controlled Release 2002; 79(1–3)71–79
   PubMed Web of Science ®Google Scholar
• Kawashima Y, Niwa T, Takeuchi H, Hino T, Itoh Y. Hollow microspheres for use as a floating controlled drug delivery system in the stomach. Journal of Pharmaceutical Sciences 1992; 81: 135–140
   PubMed Web of Science ®Google Scholar
• Machida Y, Inouye K, Tokumura T, Iwata M, Nagai T. Preparation and evaluation of intragastric buoyant preparations. Drug Design and Delivery 1989; 4(2)155–161
   PubMedGoogle Scholar
• Novotny M, Kostrica R. Fixed combination of cinnarizine and dimenhydrinate vs betahistine dimesylate in the treatment of Meniere's disease: A randomized, double-blind, parallel group clinical study. International Tinnitus Journal 2002; 8(2)115–123
   PubMedGoogle Scholar
• Oth M, Franz M, Timmermans J, Moës A. The bilayer floating capsule: A stomach-dried drug delivery system for misoprostol. Pharmaceutical Research 1992; 9: 298–302
   PubMed Web of Science ®Google Scholar
• Perumal D. Microencapsulation of ibaprofen and Eudragit® RS100 by the emulsion solvent diffusion technique. Journal of Pharmaceutical Sciences 2001; 218: 1–11
   Google Scholar
• Rainer A, Roland B. Encapsulation of water-soluble drugs by a solvent evaporation method. I. Effect of process and formulation variables on drug entrapment. Journal of Microencapsulation 1990; 7(3)347–355
   PubMed Web of Science ®Google Scholar
• Sato Y, Kawashima Y, Takeuchi H, Yamamoto H. In vitro evaluation of floating and drug releasing behaviors of hollow microspheres (microballoons) prepared by the emulsion solvent diffusion method. European Journal of Pharmaceutics and Biopharmaceutics 2003; 57(3)297–304
   Web of Science ®Google Scholar
• Sato Y, Kawashima Y, Takeuchi H, Yamamoto H. In vitro and in vivo evaluation of riboflavin-containing microballoons for a floating controlled drug delivery system in healthy humans. International Journal of Pharmaceutics 2004; 275: 97–107
   PubMed Web of Science ®Google Scholar
• Scholtz AW, Schwarz M, Baumann W, Kleinfeldt D, Scholtz HJ. Treatment of vertigo due to acute unilateral vestibular loss with a fixed combination of cinnarizine and dimenhydrinate: A double-blind, randomized, parallel-group clinical study. Clinical Therapeutics 2004; 26(6)866–877
   PubMed Web of Science ®Google Scholar
• Soppimath KS, Kulkarni AR, Aminabhavi TM. Development of hollow microspheres as floating controlled-release systems for cardiovascular drugs: Preparation and release characteristics. Drug Development and Industrial Pharmacy 2001; 27(6)507–515
   PubMed Web of Science ®Google Scholar
• Stithit S, Chen W, Price JC. Development and characterization of buoyant theophylline microspheres with near zero order release kinetics. Journal of Microencapsulation 1998; 15(6)725–737
   PubMed Web of Science ®Google Scholar
• Srivastava AK, Ridhurkar DN, Wadhwa S. Floating microspheres of cimetidine: Formulation, characterization and in vitro evaluation. Acta Pharmaceutica 2005; 55(3)277–285
   PubMedGoogle Scholar
• Streubel A, Siepmann J, Bodmeier R. Multiple unit gastroretentive drug delivery systems: A new preparation method for low density microparticles. Journal of Microencapsulation 2003; 20(3)329–347
   PubMed Web of Science ®Google Scholar
• Thanoo BC, Sunny MC, Jayakrishnan A. Oral sustained-release drug delivery systems using polycarbonate microspheres capable of floating on the gastric fluid. Journal of Pharmaceutics and Pharmacology 1993; 45(1)21–24
   PubMed Web of Science ®Google Scholar
• Togha M, Ashrafian H, Tajik P. Open-label trial of cinnarizine in migraine prophylaxis. Headache 2006; 46(3)498–502
   PubMed Web of Science ®Google Scholar
• Tokumura T, Nanba M, Tsushima Y, Tatsuishi K, Kayano M, Machida Y, Nagai T. Enhancement of bioavailability of cinnarizine from its beta-cyclodextrin complex on oral administration with DL-phenylalanine as a competing agent. Journal of Pharmaceutical Sciences 1986; 75(4)391–394
   PubMed Web of Science ®Google Scholar
• Tokumura T, Tsushima Y, Tatsuishi K, Kayano M, Machida Y, Nagai T. Enhancement of the oral bioavailability of cinnarizine in oleic acid in beagle dogs. Journal of Pharmaceutical Sciences 1987; 76(4)286–288
   PubMed Web of Science ®Google Scholar
• Turner D, Lurie Y, Finkelstein Y, Schmid T, Gopher A, Kleid D, Bentur Y. Pediatric cinnarizine overdose and toxicokinetics. Pediatrics 2006; 117(5)1067–1069
   PubMed Web of Science ®Google Scholar
• Umamaheshwari RB, Jain S, Bhadra D, Jain NK. Floating microspheres bearing acetohydroxamic acid for the treatment of Helicobacter pylori. Journal of Pharmaceutics and Pharmacology 2003; 55(12)1607–1613
   PubMed Web of Science ®Google Scholar
• Whitehead L, Fell JT, Collett JH, Sharma HL, Smith AM. An in vivo study demonstrating prolonged gastric retention. Journal of Controlled Release 1998; 55: 3–12
   PubMed Web of Science ®Google Scholar
• Yamada I, Goda T, Kawata M, Ogawa K. Application of gastric acidity-controlled beagle dog to bioavailability study of cinnarizine. Yakugaku Zasshi 1990; 110(4)280–285
   PubMed Web of Science ®Google Scholar